1 Min Read
Oct 5 (Reuters) -
* Cepheid says it has received clearance from U.S. FDA to market Xpert Xpress Strep A Source text for Eikon: Further company coverage: [ ]
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.